Fidelity Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.7M | Buy |
|
|||||
|
2025
Q1 | $13.8M | Sell |
|
|||||
|
2024
Q4 | $16.7M | Sell |
|
|||||
|
2024
Q3 | $35.4M | Sell |
|
|||||
|
2024
Q2 | $26.6M | Sell |
|
|||||
|
2024
Q1 | $36.5M | Sell |
|
|||||
|
2023
Q4 | $47.5M | Sell |
|
|||||
|
2023
Q3 | $36.6M | Buy |
|
|||||
|
2023
Q2 | $38.4M | Sell |
|
|||||
|
2023
Q1 | $40.3M | Sell |
|
|||||
|
2022
Q4 | $50M | Buy |
|
|||||
|
2022
Q3 | $40.6M | Sell |
|
|||||
|
2022
Q2 | $69.1M | Sell |
|
|||||
|
2022
Q1 | $91.2M | Sell |
|
|||||
|
2021
Q4 | $109M | Buy |
|
|||||
|
2021
Q3 | $105M | Buy |
|
|||||
|
2021
Q2 | $83.4M | Sell |
|
|||||
|
2021
Q1 | $99.9M | Sell |
|
|||||
|
2020
Q4 | $148M | Sell |
|
|||||
|
2020
Q3 | $96.2M | Sell |
|
|||||
|
2020
Q2 | $113M | Sell |
|
|||||
|
2020
Q1 | $78.9M | Sell |
|
|||||
|
2019
Q4 | $77.9M | Sell |
|
|||||
|
2019
Q3 | $89.1M | Sell |
|
|||||
|
2019
Q2 | $145M | Sell |
|
|||||
|
2019
Q1 | $175M | Sell |
|
|||||
|
2018
Q4 | $128M | Sell |
|
|||||
|
2018
Q3 | $254M | Sell |
|
|||||
|
2018
Q2 | $266M | Sell |
|
|||||
|
2018
Q1 | $201M | Buy |
|
|||||
|
2017
Q4 | $169M | Sell |
|
|||||
|
2017
Q3 | $195M | Sell |
|
|||||
|
2017
Q2 | $236M | Sell |
|
|||||
|
2017
Q1 | $414M | Buy |
|
|||||
|
2016
Q4 | $414M | Sell |
|
|||||
|
2016
Q3 | $419M | Buy |
|
|||||
|
2016
Q2 | $286M | Buy |
|
|||||
|
2016
Q1 | $370M | Buy |
|
|||||
|
2015
Q4 | $653M | Buy |
|
|||||
|
2015
Q3 | $559M | Buy |
|
|||||
|
2015
Q2 | $551M | Buy |
|
|||||
|
2015
Q1 | $331M | Buy |
|
|||||
|
2014
Q4 | $210M | Buy |
|
|||||
|
2014
Q3 | $260M | Buy |
|
|||||
|
2014
Q2 | $125M | Buy |
|
|||||
|
2014
Q1 | $85.1M | Buy |
|